Pavmed INC. 8-K Filing
Ticker: PAVM · Form: 8-K · Filed: Dec 30, 2025 · CIK: 1624326
Sentiment: neutral
Filing Stats: 1,757 words · 7 min read · ~6 pages · Grade level 13.1 · Accepted 2025-12-30 09:00:44
Key Financial Figures
- $0.001 — ch registered Common Stock, Par Value $0.001 Per Share PAVM The Nasdaq Stock Mar
- $1 — mon stock had been below the minimum of $1 per share required for continued listin
- $1.00 — he Common Stock will increase above the $1.00 per share requirement to regain complia
Filing Documents
- form8-k.htm (8-K) — 55KB
- ex3-1.htm (EX-3.1) — 12KB
- ex99-1.htm (EX-99.1) — 12KB
- 0001493152-25-029510.txt ( ) — 252KB
- pavm-20251230.xsd (EX-101.SCH) — 3KB
- pavm-20251230_lab.xml (EX-101.LAB) — 33KB
- pavm-20251230_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
03. Material Modification to Rights of Security Holders
Item 3.03. Material Modification to Rights of Security Holders. To the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this Current Report on Form 8-K (this " Current Report ") is incorporated by reference herein.
03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. As previously disclosed, at a special meeting of the Company's stockholders held on December 5, 2025, the Company's stockholders approved a reverse stock split of the Company's outstanding shares of common stock (the " Reverse Split ") at a specific ratio, ranging from 1-for-10 to 1-for-30, to be determined by the Company's board of directors (the " Board ") in its sole discretion, as well as an associated reduction in the number of shares of common stock the Company is authorized to issue (the " Reduction in Authorized Common Stock ") from 250,000,000 shares to 25,000,000 shares. Following the special meeting, the Board approved a ratio of 1-for-30 for the Reverse Split. On December 30, 2025, in order to effect the Reverse Split and the Reduction in Authorized Common Stock, the Company filed a certificate of amendment to its certificate of incorporation, as amended, pursuant to which the Reverse Split and the Reduction in Authorized Common Stock will become effective on Friday, January 2, 2026, at 12:01 a.m. Eastern Time (the " Effective Time "). Reasons for the Reverse Split The Company is effecting the Reverse Split in order to regain compliance with the continued listing requirements for the Capital Market of The Nasdaq Stock Market LLC (" Nasdaq "). As previously disclosed, on January 23, 2025, the Company received a notification letter from the Nasdaq Listing Qualifications Department stating that, for the prior 30 consecutive business days (through January 22, 2025), the closing bid price of the Company's common stock had been below the minimum of $1 per share required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). The initial notification letter stated that the Company would be afforded 180 calendar days (until July 22, 2025) to regain compliance, and that the Company could be eligible for additional time. Although the Comp